ArticleGHM open2025
The Academic Research Organization Alliance for Southeast and East Asia (ARISE) in the new era: An international trials network towards pandemic preparedness.
Article in GHM open, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 1 paper.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
1 citing paper in PubMed.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
9 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
The Academic Research Organizations (ARO) Alliance for Southeast and East Asia (ARISE), established in 2021, is a network of academic research organizations in Southeast and East Asia. Its founding vision was focused on conducting effective, high-quality clinical research and providing timely access to new medicinal products during health crises. Through its focused efforts, ARISE has fostered regional cooperation and contributed to implementing clinical trials of medical products in its network. In response to global health challenges, the Government of Japan is establishing a new organization, the Japan Institute for Health Security, with functions encompassing infectious disease control and pandemic preparedness. As ARISE continues to fulfill its mission of addressing emerging infectious diseases, the ongoing changes in its founding organization will significantly impact its operations. With this article, we aim to highlight ARISEs achievements in its first two years and to explain how its strategy has been adapted to the new organizational structure and evolving global health landscape. ARISE strives to strengthen its network collaboration and further enhance the ability of member organizations to respond rapidly and effectively to future health emergencies.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.